Background: Current guidance on the management of sepsis often applies to infection originating from abdominal or pelvic sources, which presents specific challenges and opportunities for efficient and rapid source control. Advances made in the past decade are presented in this article.
Introduction
The management of sepsis remains a significant challenge for health professionals. The Surviving Sepsis campaign, an effort to improve outcomes from sepsis launched in 2004 and sponsored by major critical care societies across the world, estimates that severe sepsis and septic shock affects millions every year, with death in one in four of those affected 1 . Statistics from England support this, showing that over 120 000 patients develop sepsis each year and more than 37 000 of these die, making sepsis the second most common cause of death after cardiovascular disease 2 . Surgeons have a significant contribution to make with regard to sepsis, because they play a central role in the management of patients in whom a surgical procedure may be needed for source control. Some 22 per cent of all patients with severe sepsis or septic shock in the International Multicentre Prevalence Study on Sepsis (IMPreSS) 3 , a recent international point prevalence audit of sepsis care, had an abdominal source.
A proportion of hospital-acquired sepsis arises as a consequence of infection resulting from complications of abdominal surgery. In the recent English National Confidential Enquiry into Patient Outcome and Death (NCE-POD) review 'Just Say Sepsis!' 4 , more than 60 per cent of patients with sepsis acquired in hospital developed this infection as a result of an invasive procedure.
Current clinical guidelines on the management of sepsis, such as those from the Surviving Sepsis Campaign 1 , the English National Institute for Health and Care Excellence (NICE) 5 and the Irish National Clinical Effectiveness Committee 6 , all emphasize that sepsis is a medical emergency with a limited window of opportunity for intervention ( Fig. 1) . Specifically, the guidelines give detailed, practical recommendations regarding the rapid recognition of sepsis, resuscitation and commencement of empirical antimicrobial therapy. In contrast, few guidelines emphasize the importance of rapid source control ( Table 1) .
The crucial importance of early source control in the management of abdominal and pelvic infection deserves to be promoted as a top priority in the multidisciplinary management of sepsis. A large European survey 8 has suggested that delayed initial intervention (beyond 24 h) remains predictive of high mortality in abdominal sepsis. The English NCEPOD study 4 found there had been a failure to provide source control in a 'sufficiently timely' manner in over 40 per cent of cases reviewed, without specifying the desirable time spans. In the present review of national and international guidance, the only detailed recommendations regarding timing to source control were issued jointly by the Department of Health and the Royal College of Surgeons of England 7 ( Table 1) .
Surgeons are increasingly required to undertake complex abdominal procedures for patients in whom underlying disease or co-morbidity is associated with increased risks of, or an adverse outcome from, abdominal sepsis, notably the elderly, and diabetic, immunosuppressed and obese patients. The aim of this systematic review was to provide an update on advances over the past decade in imaging and other diagnostic modalities, antibacterial and antifungal chemotherapy, and minimally invasive and surgical treatment of patients with complicated abdominal infection.
Methods
A search was undertaken for reports providing original data on any aspect of the clinical management of intra-abdominal infection in patients aged 18 years or more published in English during the past decade (from 1 January 2006 to 10 August 2016). Results of meta-analyses were included. Studies relevant only to specific conditions (such as diverticulitis, Crohn's disease) or procedures (for example appendicectomy, ventriculoperitoneal shunt) were excluded.
MEDLINE, the Cochrane Library and Scopus databases were searched electronically. All sources were last searched before or on 10 August 2016. MEDLINE was searched using combinations of the following search terms: 'abdominal', 'intraabdominal', 'intraperitoneal', 'infection', 'sepsis', 'peritonitis', 'surgery' and 'drainage'. The PubMed search engine was used, employing its automatic expansion of entered terms into relevant keywords and search terms, and its 'similar articles' search function. The 'limits' functionality was used. Other databases were searched using similar criteria.
Titles and abstracts of studies identified were screened and selected, based on assessment of study quality and importance to the topic of this qualitative review. Data were not formally extracted and meta-analysis was not performed. The studies included were then discussed in relation to several topical themes that emerged during the systematic review.
Data selection
Some 1869 publications were screened during database searches; 64 full-length papers and five reports by regulatory bodies were assessed, and 47 were selected for inclusion. Five key topics emerged during the review: diagnostic modalities, antimicrobial therapy, intra-abdominal fungal infection, percutaneous drainage and surgery for 
Diagnostic modalities
Cross-sectional imaging with oral positive contrast remains the standard for identifying abdominal and pelvic foci of sepsis. Orally administered contrast helps differentiation of small bowel loops from fluid collections, and may also demonstrate extraluminal leakage. Contemporary CT is more sensitive than MRI, despite its lower resolution. This is due to a significantly faster image acquisition time, which affects image quality in and near moving tissues such as small bowel. In younger patients, this advantage of CT has to be offset by the associated radiation dose.
Intra-abdominal fluid collections are often sterile; recent data suggest that approximately 40 per cent of collections drained percutaneously after abdominal surgery yield negative microbial culture results 9 . Characteristics that may aid identification of infected (as opposed to sterile) fluid collections, suggesting the need to consider measures for source control (see below), include wall enhancement, wall thickness, fluid attenuation of 20 Hounsfield units or more, entrapped gas and adjacent fat stranding 9 .
Conventional cross-sectional imaging is occasionally not sensitive enough to identify abdominal or pelvic sources of sepsis. This is particularly true in patients with prolonged and/or low-grade infection associated with complex abdominal pathology, such as in the open abdomen following multiple laparotomies. In such cases, other modalities may be required to identify small collections or areas of infected tissue. Labelled leucocyte scintigraphy has traditionally been used in these circumstances, but several recent case series provide data to support a role for PET in this scenario. The largest series 10 reported a 90 per cent utility for [ 18 F]fluorodeoxyglucose PET/CT in identifying the cause of pyrexia of unknown origin in 48 patients, several of whom had an infectious source in the abdomen or pelvis. Further case reports 11, 12 have suggested that PET can be used to diagnose otherwise occult abdominal sources of infection, and one recent case report 13 comparing PET with labelled leucocyte scintigraphy in the diagnosis of prosthetic vascular graft infection in the abdomen suggested that PET may have higher sensitivity.
Patients with severe sepsis or septic shock, associated with haemodynamic instability, are on the opposite side of the diagnostic spectrum in abdominal infection. Safe and timely transport to a CT scanner may be difficult in such patients, and may expose the patient to additional risks. When an abdominal or pelvic source of sepsis is likely in such patients, urgent surgical exploration has traditionally been the immediate next step. Patients in this category would be well served by a mobile diagnostic modality to minimize the risks associated with transferring an unstable, ventilated patient to a scanner, or of a negative (or at least non-therapeutic) laparotomy. This problem has been addressed by several case series, suggesting so-called 'bedside laparoscopy' in the ICU. The latest, and largest, such series 14 reported the outcomes in 62 patients in an Italian centre. The authors created a sterile field, induced pneumoperitoneum at 8-10 mmHg, and explored the peritoneum within a mean operating time of 38 min. A single 5-mm working port was used and therapeutic interventions were not attempted at the bedside laparoscopy. No complications occurred, and a source of sepsis was identified in 43 of the 62 patients, including cholecystitis, perforated viscera and ischaemic bowel 14 . Although this concept is intriguing, the authors did not comment on the false-negative rate or the appropriate management for patients in whom bedside laparoscopy proved negative.
In postoperative patients at high risk of developing intra-abdominal sepsis, the opportunity exists for prospective monitoring to detect the occurrence or recurrence of sepsis. Most work in this area has focused on systemic markers of inflammation (C-reactive protein or procalcitonin), but these markers have low specificity for abdominal sources of sepsis 15, 16 . Preliminary work suggests that sampling peritoneal fluid for measurement of concentrations of cytokines such as interleukin (IL) 6 and IL-10 via conventional abdominal drains 17 , or lactate/pyruvate ratios via smaller microdialysis catheters 18 , may represent alternative and more specific diagnostic methods.
Blood cultures can aid in the diagnosis of sepsis and point to likely sources. A drawback in the context of abdominal sepsis, however, is that it typically takes several days to identify pathogens and, if antibiotics have already been started, cultures may be falsely negative. As a complement to blood cultures, a commercially available battery of PCR assays that target ribosomal DNA sequences of common bacteria and fungi has been developed and evaluated in a series of small studies 19 . These tests can provide results on small peripheral blood samples within a few hours and are unaffected by the use of antibiotics, as they rely on the detection of bacterial DNA rather than culture of living organisms. Recently, this diagnostic modality was evaluated in a large prospective multicentre study in critically ill patients 20 , which suggested that, although the sensitivity was probably too limited in this setting for widespread clinical use, the principle was promising. It remains to be seen whether this test could ever be developed to make it sufficiently sensitive for exclusion of sepsis in critically ill patients that clinicians would be able confidently to withhold broad-spectrum antibiotics given a negative result.
Antimicrobial therapy
Recent guidelines on sepsis emphasize rapid commencement of empirical antimicrobial therapy, based on data showing a direct and strong relationship between the timeliness of appropriate therapy and survival 5, 21 . If and when available, blood and source cultures and sensitivity assays should guide therapy. What has been less clear is the optimal duration of therapy once source control of abdominal infection has been achieved. Contrary to conventional wisdom, a large retrospective study at the University of Virginia 22 demonstrated that longer duration of treatment was associated not only with an excess of secondary extra-abdominal infections but also with higher mortality. The same group then demonstrated, in a prospective clinical trial 23 undertaken in patients with abdominal infection, that a fixed-duration course of antibiotics lasting for 4 days was associated with similar clinical outcomes to a policy of extending therapy until 2 days after resolution of infectious symptoms. Importantly, the group demonstrated that this was also the case in a subgroup of patients with clinical sepsis, as opposed to milder degrees of infection 24 . High-level evidence would thus appear to support a treatment duration of only 4 days for systemic antimicrobial therapy, following adequate source control in abdominal sepsis.
Limiting exposure to antimicrobial agents is an important part of an ongoing wider effort to rationalize and standardize the use of antimicrobials across healthcare in order to curtail the increasing emergence of polymicrobial resistance. Data on antimicrobial resistance are growing at a rapid pace as such resistance evolves and spreads rapidly between geographical locations, and between strains and species. This body of literature is too large to review presently, and much will be of peripheral interest to surgeons, but it underlines the crucial importance of antimicrobial stewardship under the guidance of institutional infectious diseases expertise. Such antimicrobial stewardship includes selecting optimal antimicrobials based on clinical presentation and institutional characteristics of bacterial and fungal strains, implementing education programmes, daily review of patients by infectious disease specialists, and completing relevant audit cycles. Such antibiotic stewardship programmes have been shown to result in marked and sustained improvement in clinically effective antimicrobial usage, and are now considered an integral part of contemporary surgical practice 25, 26 .
Intra-abdominal fungal infections
The incidence of fungal infection or co-infection in intra-abdominal and pelvic abscesses and peritonitis appears to be increasing, and the associated morbidity and mortality rates are higher than those associated with bacterial abdominal infection. These points were highlighted by a European and South American multicentre study 27 27 . One explanation for the relatively poor outcomes from fungal sepsis is the difficulty in diagnosing such infections from blood samples, and even in directly sampled pus or ascites. Fungi grow slowly in conventional culture media, standard culture has a low sensitivity for diagnosis, and therapy is most often started on clinical suspicion -or even prophylactically in high-risk populations such as critically ill patients or transplant recipients. Unfortunately, a recent study 28 of 11 000 patients undergoing abdominal surgery confirmed that prophylactic or liberal use of fluconazole is associated with subsequent infection by fluconazole-resistant species such as C. glabrata and C. parapsilosis.
A potential and more rapid alternative to fungal culture is detection in the circulation of fungal cell components or antibodies directed against such components. A recent Swiss multicentre study 29 demonstrated that 1,3-β-D-glucan antigenaemia was superior to fungal culture. This, or related rapid methods, may therefore emerge as standard assays in at-risk populations to guide early and targeted therapy. Until such methods are proven and widely available, fungal infection and antifungal resistance will remain a difficult challenge in patients with abdominal infection.
Percutaneous drainage
In patients with systemic signs of infection, most authorities recommend source control by draining all collections larger than 3 cm 30, 31 . Traditionally, such drainage was achieved by surgical exploration. Percutaneous drainage of abdominal abscesses using CT guidance was first described in 1977 as an alternative to surgical drainage, and has since become the standard of care 32 . Thus, urgent surgery for intra-abdominal abscess alone is now rarely indicated;
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nationwide data from the USA show that the number of percutaneous drainage procedures for abdominal abscesses more than doubled between 2001 and 2013, while the laparotomy rate fell by 21 per cent during the same time interval 33 . Laparotomy, or in some cases laparoscopy, is still required in situations where percutaneous drainage is unlikely to provide adequate source control. Examples include: infections with no abscess cavity wall (such as in uncontrolled visceral perforation); complex and multifocal abscesses where percutaneous drainage is not feasible even with multiple drains; abscess cavities associated with substantial anastomotic dehiscence unlikely to heal despite adequate abscess drainage; and cavities where drainage is not sufficient to achieve resolution. A recent large case series 34 reported an overall 78 per cent success rate in achieving source control of postoperative abdominopelvic abscesses by one or two drain insertions, in line with previous findings.
The available guidance on the timescales required for source control in sepsis in surgical patients, although often brief, emphasizes that percutaneous drainage or surgery are steps that need to be taken rapidly ( Table 1) . These recommendations are not fully evidence-based, but represent a compromise between the need to treat sepsis urgently in patients most at risk and the resources typically available to treat all patients presenting with an infection amenable to surgical source control. However, the ability to deliver treatment within even these targets remains a considerable logistical challenge to those treating patients with abdominal sepsis. Out-of-hours access to cross-sectional imaging and interventional radiology, in particular, are practical difficulties in meeting available benchmarks.
Several novel drainage approaches have been described in recent years. Although the liver and stomach can be traversed safely with a needle for drainage 31, 35 , several anatomical sites cannot be safely accessed percutaneously via the standard anterior approach. One common such site is the deep pelvis, inaccessible owing to anatomical obstacles to anterior approaches, including the bony pelvis, bladder, uterus, iliac vessels and hypogastric nerves. The deep pelvis and presacral space are common sites for postoperative abscesses following anterior resection, ileal pouch-anal anastomosis and other pelvic procedures. The transgluteal approach, an alternative approach through the greater sciatic foramen posterior to the sciatic nerve, was therefore proposed in the 1980s. Recent data confirm that this now widely practised approach is both safe and effective; one recent case series 36 of 39 patients reported successful source control in 38 individuals, with no complications apart from pain. Pain during insertion can be troublesome and is managed by a combination of local and systemic anaesthesia, including inhaled nitrous oxide.
An alternative and more recent approach for deep pelvic collections is the transrectal or transcolonic route. Accessing collections abutting the rectum by palpation and aspiration through the rectal wall is a traditional approach, but several groups have shown that smaller or slightly more distal collections can be identified, and drained, by means of transanal endoscopic ultrasonography. In one such series 37 the experience of draining deep pelvic abscesses in this way was described in 14 patients following low anterior resection or acute diverticulitis; infection in all but one patient resolved without the need for surgery. Another group 38 described drainage through the distal colon rather than the rectum in some patients.
Several centres have described a similar approach to otherwise inaccessible collections in the upper abdomen. Difficult sites to drain through a standard anterior approach include the retrogastric and retroperitoneal spaces. Although drainage can be performed through the anterior and posterior walls of the stomach in some patients 31 , endoscopic transgastric drainage is an alternative and potentially safer approach. This technique is similar to the standard drainage procedure for pancreatic pseudocysts, but here a thin nasocystic drain can be placed using ultrasound-guided upper gastrointestinal endoscopy, and then removed as the abscess resolves. Two reports 38, 39 described this experience in four patients, all with a favourable outcome, enabling surgery to be avoided.
Independently of the technique used to access a collection, great variability exists between centres, and countries, in the subsequent management of drains. This relates to the use of saline flushing and the method of determining when to remove the drain. Data to guide best practice remain sparse. Pragmatically, the indications for flushing a drain include potential blockage and, in long-term drains, impending build-up of an infected crust along the lumen. Small volumes should be used to allow the cavity to close without regular disruption and potential spread of infection. Some data suggest that shorter drainage duration is a risk factor for recurrence of the abscess 34 , and these authors recommend that drains be removed 48 h after the output has stopped, and with repeat cross-sectional imaging at this time showing resolution of the collection. In North American centres, sinography using water-soluble contrast showing resolution of the cavity is required routinely before drain removal (Fig. 2) 30 . The best approach here remains unclear. 
Surgery
Although early and appropriate antibiotic therapy remains critically important with regard to the management of abdominal sepsis, prompt source control, by achieving drainage or by resection and/or debridement of infected tissue, including exteriorization of leaking anastomoses or enterotomies, remains essential for successful management of abdominal infection. Percutaneous drainage of abscesses is frequently possible and usually represents the optimal approach in critically ill patients who are often compromised by recent trauma, abdominal surgery (or both); however, surgery remains essential for intra-abdominal abscesses that cannot be accessed by radiological means (including multiple interloop abscesses) and abdominal infection associated with a source that requires excision, such as a leaking intestinal suture line or ischaemic tissue. Recent controversy in the surgical management of complex abdominal infection has focused on the potential benefit of leaving the abdomen open where there is severe abdominal infection, often necessitating repeated surgical debridement, or where there is concern regarding the development of intra-abdominal hypertension (IAH). IAH and abdominal compartment syndrome have long been recognized to compromise critical care of surgical patients, but Al-Bahrani and colleagues 40 have confirmed a pathophysiological relationship between abdominal compartment syndrome and gut barrier dysfunction in patients with abdominal sepsis or acute pancreatitis. Impaired gut barrier function was inferred from systemic exposure to endotoxin and increased plasma procalcitonin concentration, and abdominal compartment syndrome in this study was associated with significantly impaired gut barrier function, which improved with resolution of the raised intra-abdominal pressure.
Concerns regarding IAH and abdominal compartment syndrome, and the need to consider further laparotomy for the treatment of abdominal sepsis, have resulted in an increasing tendency to view open abdominal management as an early strategic decision to be made in managing complicated abdominal infection, rather than a late necessity. Kim and co-workers 41 showed that 22 per cent of patients undergoing emergency surgery for intra-abdominal catastrophes (at least 65 per cent of whom had abdominal sepsis) required a further unplanned laparotomy before hospital discharge or death.
Relaparotomy was more likely to be required in patients with peripheral arterial disease, alcohol abuse, obesity (defined here as BMI above 29 kg/m 2 ), ischaemic bowel and an interval greater than 60 h from time of first symptom onset to undertaking laparotomy. The presence of two or more factors (found in almost 30 per cent of patients) was associated with a 55 per cent rate of relaparotomy, and three or more factors with a relaparotomy rate of 83 per cent. Perhaps unsurprisingly, the need for relaparotomy was associated with a fourfold increase in the rate of hospital death. There was little evidence to support leaving the abdomen open in all patients, however, confirming the findings of previous studies that have also failed to demonstrate a clear survival benefit for leaving the abdomen open. A highly selective strategy for leaving the abdomen open would therefore seem more appropriate, principally where there is difficulty in securing source control (including gross faecal contamination), mesenteric ischaemia where a second-look laparotomy has been planned, where there is concern regarding IAH, and in patients with three or more of the above risk factors for relaparotomy.
Leaving the abdomen open may prevent (or at least reduce) IAH and abdominal compartment syndrome in patients with severe abdominal sepsis, but it requires a substantial resource commitment from surgical and critical care teams, and the health economic considerations may be formidable. Bruns et al. 42 studied the outcome of open abdominal management in a non-trauma setting and noted that older patients (above 80 years of age) were no more likely to die in hospital, but significantly more likely to have died within 6 months of discharge. Whether this reflects age alone, co-morbidity or underlying disease is unclear. However, more than 70 per cent of all survivors required continuing care after discharge from hospital.
Treatment of abdominal sepsis with an open abdomen, even if successful, also presents its own challenges, notably with regard to management of the open abdominal wound and the development of complications attributable to leaving the abdomen open, specifically enteroatmospheric fistulation (Fig. 3) . Despite concerns that the open abdomen is inherently fistulogenic and enteroatmospheric fistulas in this setting may be associated with substantially increased mortality rates, and that negative-pressure wound therapy (NPWT), at least theoretically, might increase fistulation rate, a study of UK practice 43 noted that NPWT was not associated with increased development of fistulas in patients treated with an open abdomen (mostly for sepsis). The rate of primary fascial closure was low in this study (41 per cent) however, suggesting that NPWT appears to be being used as a primary form of therapy in the majority of patients with an open abdomen associated with sepsis, as opposed to its use in trauma. The number of patients needed to be randomized prospectively to determine whether NPWT does result in an excessive rate of fistula formation exceeded 2000 in each arm, making it extremely unlikely that this question will ever be satisfactorily addressed.
Improvements in critical care have resulted in an increasing need for surgeons to consider strategies for early abdominal wall reconstruction in patients who survive. Definitive fascial closure is less likely to occur in those with pre-existing respiratory morbidity, pulmonary oedema, This suggests that, if the ultimate goal is to close the abdomen, an initial decision to leave the abdomen open may be strategically beneficial (compared with initial closure followed by relaparotomy on demand). Early (as opposed to delayed) second-and (where required) third-look laparotomy were also associated with higher rates of fascial closure 45 , which appeared to be associated with lower hospital mortality.
A variety of methods for managing the open abdominal wound have been described, including NPWT, NPWT with continuous fascial traction, dynamic retention sutures, the Wittmann patch (artificial burr), Bogota bag, artificial mesh, zipper and 'loose packing' techniques. It still remains unclear which method is to be preferred. Atema and co-workers 46 compared these open abdominal management techniques in a systematic review of 74 studies comprising 4358 patients, 3461 of whom had peritonitis. The authors noted that the most widely used technique was NPWT, and concluded that most studies were of poor methodological quality; it was not possible to show differences in mortality, enterocutaneous fistula or fascial closure rates, even between the most popular techniques (NPWT alone and NPWT with fascial traction). Given the numbers required to determine whether fistulation is more likely with NPWT, it seems unlikely that the ideal method for managing the open abdomen will ever be addressed by a single trial, and the heterogeneity of patient groups and endpoints in such studies makes meaningful meta-analysis extremely difficult to undertake. One small RCT 47 , not included in Atema's systematic review 46 , that included patients undergoing open abdominal management for both trauma and peritonitis appears to show a significant reduction in mortality in patients treated with a commercially available NPWT system, compared with results in patients treated with an in-house 'vac pack' system. The difference in outcome did not seem to be related to plasma inflammatory markers or cytokine concentrations, or fascial closure rate, and may be explained by a type I statistical error.
Discussion
Sepsis is an important cause of morbidity and mortality in contemporary healthcare. Timely and adequate source control remains a vital component of definitive sepsis management, and is key to a successful outcome in complicated abdominal infection. To be able to provide this, however, early and accurate diagnosis is essential. Novel options are emerging in diagnosis, systemic therapy, radiological approaches and surgical techniques for the management of complicated abdominal infection, holding the promise of improved outcomes. The logistics of emergency CT capacity and percutaneous drainage, particularly outside weekday hours, also remain a challenge in many centres. Priorities for future research and development include the particular challenges posed by fungal infections as well as antimicrobial, including antifungal, resistance. A better understanding of when to leave the abdomen open, how to manage an open abdomen most safely and effectively and with the least morbidity, and how to reconstruct the abdominal wall most effectively in patients who survive a period with an open abdomen remain key surgical goals.
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